Showing results (71-80 of 322) with videos related to
Sort By:
Pageof 33
Biotherapy (Dordrecht, Netherlands)|January 1, 1991
The effect of photosensitive dye platonin on juvenile rheumatoid arthritisF Motoyoshi, N Kondo, H Ono, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1991
A regimen of surgical adjuvant immunotherapy for cancer with interleukin 2 and lymphokine-activated killer cells. Basis, clinical toxicity, and immunomodulatory effectsT Yano, T Ishida, I Yoshino, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Induction of resistance in mice against murine cytomegalovirus by cellular components of Lactobacillus caseiT Ohashi, Y Minamishima, T Yokokura, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
The in vivo and in vitro effects of interleukin-1 and tumor necrosis factor on murine cytomegalovirus infectionJ W van der Meer, R H Rubin, M Pasternack, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1996
Some properties and protective activity of specific DLE against Salmonella cholerae suis infectionA Arnaudov, N TziporkovBiotherapy (Dordrecht, Netherlands)|April 29, 1998
Oral administration of HSP-containing E. coli extract OM-89 has suppressive effects in autoimmunity. Regulation of autoimmune processes by modulating peripheral immunity towards hsp's?U Wendling, J C FarineBiotherapy (Dordrecht, Netherlands)|January 1, 1990
Synergistic effects of TGIF and interferon gamma (IFN-gamma) on tumor cell growth. TGIF and IFN-gammaM Katano, H Yamamoto, M Nakamura, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Interleukin-2. The experience of the Rotterdam Cancer Institute; Daniel den Hoed KliniekG Stoter, S H Goey, A M Eggermont, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Induction of endogenous tumor necrosis factor by OK-432 in ovarian cancer patients with ascitesH Mori, N Itoh, Y Yamada, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Options for the treatment of serious infections with interleukin-1J W van der MeerPageof 33